Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2014
09/18/2014US20140275173 Oxabicyclo [2.2.2] acid gpr120 modulators
09/18/2014US20140275159 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275157 Method and products for enhancing cellular uptake of drug and dietary supplements
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275139 Mdr method and products for treating hiv/aids
09/18/2014US20140275138 Method and products for treating diabetes
09/18/2014US20140275131 Organic compounds
09/18/2014US20140275128 Method of providing ocular neuroprotection
09/18/2014US20140275114 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275101 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
09/18/2014US20140275098 Compositions and methods of treating pulmonary hypertension
09/18/2014US20140275082 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/18/2014US20140275078 Compositions and methods for treating cancer using pi3kb inhibitor and mapk pathway inhibitor, including mek and raf inhibitors
09/18/2014US20140275072 Morpholinylbenzotriazines for use in cancer therapy
09/18/2014US20140275057 Novel compounds and compositions for the inhibition of nampt
09/18/2014US20140275039 Abuse deterrent compositions and methods of use
09/18/2014US20140275038 Abuse deterrent compositions and methods of use
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275003 Biaryl amide compounds as kinase inhibitors
09/18/2014US20140274980 Compound
09/18/2014US20140274978 Phytosterol spirostane and spirostene derivatives having a wide variety of utilities in humans and other animals
09/18/2014US20140274933 Phthalazinone compounds and methods for the treatment of cystic fibrosis
09/18/2014US20140274926 Compounds and compositions for the treatment of parasitic diseases
09/18/2014US20140274913 Methods for treating inflammation, autoimmune disorders and pain
09/18/2014US20140274896 Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
09/18/2014US20140274895 Methods And Non-Immunogenic Compositions For Treating Inflammatory Disorders
09/18/2014US20140274893 Methods and Acellular Compositions For Treating Inflammatory Disorders
09/18/2014US20140274890 Treatment for diabetes in patients inappropriate for metformin therapy
09/18/2014US20140274889 Cardio- and renoprotective antidiabetic therapy
09/18/2014US20140274875 Hemostatic Compositions And Methods
09/18/2014US20140274872 Compositions and treatments based on cadherin modulation
09/18/2014US20140273074 Yeast screens for treatment of human disease
09/18/2014US20140271957 Composition containing an essential oil product and method for using such to maintain normal levels of testosterone
09/18/2014US20140271955 Compounds and methods for inducing chondrogenesis
09/18/2014US20140271949 Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting
09/18/2014US20140271946 Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
09/18/2014US20140271943 Dietary Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting
09/18/2014US20140271931 Anti-Acne Topical Films
09/18/2014US20140271927 Composition and method for treating neuropathy
09/18/2014US20140271923 Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
09/18/2014US20140271922 Pirenzepine as an agent in cancer treatment
09/18/2014US20140271921 Pharmaceutical composition
09/18/2014US20140271915 Use of derivatives containing c-o-p bonds in patients with kidney failure
09/18/2014US20140271911 Lithium and a beta-secretase inhibitor for the treatment of alzheimer's disease
09/18/2014US20140271881 Antiseptic composition
09/18/2014US20140271879 Fine dry particulate retinoid active agent compositions and topical formulations including the same
09/18/2014US20140271876 Ophthalmic formulations
09/18/2014US20140271870 Treatment of pain using protein solutions
09/18/2014US20140271864 Therapeutic compositions for bone repair
09/18/2014US20140271842 Tofacitinib oral sustained release dosage forms
09/18/2014US20140271819 Onapristone polymorphic forms and methods of use
09/18/2014US20140271808 Systems and methods for delivery of peptides
09/18/2014US20140271735 Use of calcitonin in osteoarthritis
09/18/2014US20140271734 Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
09/18/2014US20140271732 Wound healing using topical systems and methods
09/18/2014US20140271729 Use of biogenic amines spermine and spermidine for the homeopathic treatment of hormone imbalances
09/18/2014US20140271722 Allergen dosage form
09/18/2014US20140271710 Liquid stable bovine virus vaccines
09/18/2014US20140271681 High Affinity Human Antibodies to Human IL-4 Receptor
09/18/2014US20140271674 Methods and materials for treating cancer
09/18/2014US20140271667 Methods and Compositions for Neoadjuvant Therapy
09/18/2014US20140271664 Therapeutic use of antibodies to hgf
09/18/2014US20140271662 Pyrazole derivatives as protein kinase modulators
09/18/2014US20140271661 Monoclonal antibodies against antithrombin beta
09/18/2014US20140271658 Anti-il-33 antibodies and uses thereof
09/18/2014US20140271654 Methods for treating bone gap defects
09/18/2014US20140271653 Human antibodies to respiratory syncytial virus f protein and methods of use thereof
09/18/2014US20140271642 Il-33 antagonists and uses thereof
09/18/2014US20140271638 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
09/18/2014US20140271624 Anti-notch nrr antibodies and methods using same
09/18/2014US20140271618 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
09/18/2014US20140271612 Treatment Method and Product for Uterine Fibroids using Purified Collagenase
09/18/2014US20140271604 HDAC Inhibitor Polymorphic Forms and Methods of Use
09/18/2014US20140271597 Treatment of ophthalmic conditions
09/18/2014US20140271595 Use of a combination of d-aspartic and l-aspartic acids or salts thereof for the treatment of male infertility
09/18/2014US20140271594 Equine supplement
09/18/2014US20140271589 Treatment of collagen defects using protein solutions
09/18/2014US20140271574 Methods and compositions for treating congestive heart failure
09/18/2014US20140271558 Dietary Supplements Including Glucan and Fulvic Acid
09/18/2014US20140271555 Activating adiponectin by casein hydrolysate
09/18/2014US20140271547 Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
09/18/2014US20140271543 Pyridin-2(1h)-one derivatives as jak inhibitors
09/18/2014US20140271541 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/18/2014US20140271540 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one, Salts thereof And Methods of Using The Same in Combination Therapy
09/18/2014US20140271488 Chiral compounds of varying conformational rigidity and methods of synthesis
09/18/2014US20140271470 Targeted theranostics for metastatic prostate cancer
09/18/2014US20140271466 HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
09/18/2014US20140271465 Matrix metalloprotease (mmp) targeted agents for imaging and therapy
09/18/2014US20140271464 Therapeutic use of antibodies to hgf
09/18/2014US20140271459 Antibodies to hgf and compositions containing
09/18/2014US20140271458 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
09/18/2014US20140271457 Dual Specific Binding Proteins Directed Against TNF
09/18/2014US20140271454 Cell-synthesized particles
09/17/2014EP2777706A1 Methods for increasing the production or activity of catalase
09/17/2014EP2777701A1 Composition for preventing the occurrence of a cardiovascular event in multiple risk patient comprising the ethyl ester of all-cis-5,8,11,14,17-icosapentaenoic acid
09/17/2014EP2777694A1 Hypoxia-Targeted Polymeric Micelles for Cancer Therapy and Imaging
09/17/2014EP2776046A1 Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound
09/17/2014EP2776036A1 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
09/17/2014EP2776021A1 Administration of a bis(thiohydrazide amide) compound for treating cancers
09/16/2014US8836218 Methods of treatment using combination therapy
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 1151